The primary outcome of this study was the first diagnosis of CRC within 15 years from the initial treatment of GLP-1RAs or non-GLP-1RA diabetes medications (insulin, metformin, alpha-glucosidase inhibitors, dipeptidyl-peptidase-4 inhibitors (DPP-4i), sodium-glucose cotransporter-2 inhibitors (SGLT2i), sulfonylureas (SU), and thiazolidinediones (TZD))
Because tirzepatide activates dual pathways, there has been speculation that it might preferentially protect muscle
Enhancing Lipid Profile Management: GLP-1 medications may improve cholesterol levels, further supporting heart health
Eyelid entropion should be treated as the turned in lashes can cause damage to the cornea, with vision loss, in addition to eye irritation, redness, and tearing
Acids 31 , 631647 (2023)